Apogenix AG

HERA

Medical services relating to tumor necrosis factor superfamily TNF-SF; human healthcare services relating to tumor necrosis factor superfamily TNF-SF; rental and leasing of items relating to the provision of the aforementioned services, namely, rental of medical equipment; consulting and information relating to medical and human healthcare services relating to tumor necrosis factor superfamily TNF-SF;Scientific services, namely, pharmaceutical research relating to tumor necrosis factor superfamily TNF-SF; scientific and technological services in the nature of pharmaceutical research relating to tumor necrosis factor superfamily TNF-SF; rental and leasing of items relating to the provision of services in the field of cancer and immunology, namely, rental of laboratory apparatus and instruments; consulting and information relating to pharmaceutical research in the field of tumor necrosis factor superfamily TNF-SF;

HERA-CD137

HERA-CD ONE HUNDRED THIRTY SEVEN; HERA-CD ONE THREE SEVEN;Scientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety;

HERA-CD27

HERA-CD TWENTY SEVEN; HERA-CD TWO SEVEN;Scientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety;

HERA-CD40

HERA-CD FORTY; HERA-CD FOUR ZERO;Scientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety;

HERA-GITR

Scientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety;

HERA-LIGAND

Scientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to trivalent or hexavalent fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to trivalent or hexavalent fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding trivalent or hexavalent fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding trivalent or hexavalent fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety;

HERA-LIGHT

Scientific services, namely, scientific and pharmaceutical research in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific and technological services, namely, protein design and protein engineering in the field of oncology and immunology relating to fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety; scientific consulting services in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety and providing scientific information in the field of protein design and protein engineering regarding fusion proteins with tumor necrosis factor superfamily (TNF-SF) moiety;